skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,043  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Journal Title: Business Wire remove subject: Product Development remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
NICHD ANNOUNCES RESULTS FROM PHASE III CLINICAL TRIAL FOR NORTH AMERICAN VACCINE'S DTaP VACCINE
Material Type:
Newspaper Article
Add to My Research

NICHD ANNOUNCES RESULTS FROM PHASE III CLINICAL TRIAL FOR NORTH AMERICAN VACCINE'S DTaP VACCINE

Business Wire, 1994-11-22, p.11221185

COPYRIGHT 1994 Business Wire, Inc.

Digital Resources/Online E-Resources

2
NORTH AMERICAN VACCINE ANNOUNCES NEW NIH RELEASE TO CLARIFY CLINICAL TRIAL RESULTS
Material Type:
Newspaper Article
Add to My Research

NORTH AMERICAN VACCINE ANNOUNCES NEW NIH RELEASE TO CLARIFY CLINICAL TRIAL RESULTS

Business Wire, 1994-12-01, p.12011303

COPYRIGHT 1994 Business Wire, Inc.

Digital Resources/Online E-Resources

3
CLINICAL DATA ON INVESTIGATIONAL VACCINES PRESENTED AT 95TH GENERAL MEETING OF THE ASM IN WASHINGTON, DC
Material Type:
Newspaper Article
Add to My Research

CLINICAL DATA ON INVESTIGATIONAL VACCINES PRESENTED AT 95TH GENERAL MEETING OF THE ASM IN WASHINGTON, DC

Business Wire, 1995-05-24, p.5241163

COPYRIGHT 1995 Business Wire, Inc.

Digital Resources/Online E-Resources

4
Large-scale trial establishes benefits of long-term management of prostate disease (PART III OF V)
Material Type:
Newspaper Article
Add to My Research

Large-scale trial establishes benefits of long-term management of prostate disease (PART III OF V)

Business Wire, 1995-11-01

COPYRIGHT 1995 Business Wire, Inc.

Digital Resources/Online E-Resources

5
Large-scale trial establishes benefits of long-term management of prostate disease (PART V OF V)
Material Type:
Newspaper Article
Add to My Research

Large-scale trial establishes benefits of long-term management of prostate disease (PART V OF V)

Business Wire, 1995-11-01

COPYRIGHT 1995 Business Wire, Inc.

Digital Resources/Online E-Resources

6
Large-scale trial establishes benefits of long-term management of prostate disease (PART IV OF V)
Material Type:
Newspaper Article
Add to My Research

Large-scale trial establishes benefits of long-term management of prostate disease (PART IV OF V)

Business Wire, 1995-11-01

COPYRIGHT 1995 Business Wire, Inc.

Digital Resources/Online E-Resources

7
Large-scale trial establishes benefits of long-term management of prostate disease (PART I OF V)
Material Type:
Newspaper Article
Add to My Research

Large-scale trial establishes benefits of long-term management of prostate disease (PART I OF V)

Business Wire, 1995-11-01

COPYRIGHT 1995 Business Wire, Inc.

Digital Resources/Online E-Resources

8
New Study Finds Almost 90% of Americans Expect to Face a Potentially Serious Health Condition in the Next Five Years
Material Type:
Newspaper Article
Add to My Research

New Study Finds Almost 90% of Americans Expect to Face a Potentially Serious Health Condition in the Next Five Years

Business Wire, 2004-11-10, p.1

Copyright Business Wire Nov 10, 2004

Digital Resources/Online E-Resources

9
Preliminary Results from the Estracure Phase II Clinical Trial
Material Type:
Newspaper Article
Add to My Research

Preliminary Results from the Estracure Phase II Clinical Trial

Business Wire, 2005-10-28

COPYRIGHT 2005 Business Wire, Inc.

Digital Resources/Online E-Resources

10
FDA Vaccines Advisory Committee Unanimously Agrees That Clinical Data from 70,000-Infant Phase III Trials Support the Efficacy and Safety of ROTATEQ(R), Merck's Investigational Vaccine for Rotavirus Gastroenteritis
Material Type:
Newspaper Article
Add to My Research

FDA Vaccines Advisory Committee Unanimously Agrees That Clinical Data from 70,000-Infant Phase III Trials Support the Efficacy and Safety of ROTATEQ(R), Merck's Investigational Vaccine for Rotavirus Gastroenteritis

Business Wire, 2005-12-14

COPYRIGHT 2005 Business Wire, Inc.

Digital Resources/Online E-Resources

11
MCRI Granted FDA Approval to Conduct Reduced Anticoagulation Clinical Trial of On-X Prosthetic Heart Valve; Successful Completion Could Result in First-Ever Low-Dose Anticoagulation Therapy Recommendations for a Mechanical Heart Valve
Material Type:
Newspaper Article
Add to My Research

MCRI Granted FDA Approval to Conduct Reduced Anticoagulation Clinical Trial of On-X Prosthetic Heart Valve; Successful Completion Could Result in First-Ever Low-Dose Anticoagulation Therapy Recommendations for a Mechanical Heart Valve

Business Wire, 2006-01-10

COPYRIGHT 2006 Business Wire, Inc.

Digital Resources/Online E-Resources

12
Healthy Eating Trends: CPG Industry Taking Huge Leap Forward to Meet Consumers' Health and Wellness Needs
Material Type:
Newspaper Article
Add to My Research

Healthy Eating Trends: CPG Industry Taking Huge Leap Forward to Meet Consumers' Health and Wellness Needs

Business Wire, 2006-01-31, p.1

Copyright Business Wire Jan 31, 2006

Digital Resources/Online E-Resources

13
TYSABRI(R) Two-Year Phase III Multiple Sclerosis Clinical Trial Results and Safety Evaluation Published in New England Journal of Medicine; TYSABRI Currently Under Review with U.S. and European Regulatory Authorities
Material Type:
Newspaper Article
Add to My Research

TYSABRI(R) Two-Year Phase III Multiple Sclerosis Clinical Trial Results and Safety Evaluation Published in New England Journal of Medicine; TYSABRI Currently Under Review with U.S. and European Regulatory Authorities

Business Wire, 2006-03-01

COPYRIGHT 2006 Business Wire, Inc.

Digital Resources/Online E-Resources

14
Antares Announces FDA Acceptance of Licensee's NDA; Transdermal Estradiol Gel is Antares' First ATD(TM) Gel Product Potentially Approvable By FDA
Material Type:
Newspaper Article
Add to My Research

Antares Announces FDA Acceptance of Licensee's NDA; Transdermal Estradiol Gel is Antares' First ATD(TM) Gel Product Potentially Approvable By FDA

Business Wire, 2006-04-21

COPYRIGHT 2006 Business Wire, Inc.

Digital Resources/Online E-Resources

15
IDM Pharma Receives Special Protocol Assessment from FDA for Phase 2/3 Trial of Bexidem for Superficial Bladder Cancer
Material Type:
Newspaper Article
Add to My Research

IDM Pharma Receives Special Protocol Assessment from FDA for Phase 2/3 Trial of Bexidem for Superficial Bladder Cancer

Business Wire, 2006-06-13

COPYRIGHT 2006 Business Wire, Inc.

Digital Resources/Online E-Resources

16
Daiichi Pure Chemicals, Toshiba and Toshiba Hokuto Electronics Agree to Develop DNA Chip Diagnostics Business; Aiming for Japan's First Practical Use of a DNA Chip
Material Type:
Newspaper Article
Add to My Research

Daiichi Pure Chemicals, Toshiba and Toshiba Hokuto Electronics Agree to Develop DNA Chip Diagnostics Business; Aiming for Japan's First Practical Use of a DNA Chip

Business Wire, 2006-07-11

COPYRIGHT 2006 Business Wire, Inc.

Digital Resources/Online E-Resources

17
Needlestick Prevention Experts Identify Need for Better Safety Syringe Design, as Well as Improved Training and Reporting; `The Inviro Initiative' Gives Voice to Industry Thought Leaders and Advocates
Material Type:
Newspaper Article
Add to My Research

Needlestick Prevention Experts Identify Need for Better Safety Syringe Design, as Well as Improved Training and Reporting; `The Inviro Initiative' Gives Voice to Industry Thought Leaders and Advocates

Business Wire, 2006-08-30, p.1

Copyright Business Wire Aug 30, 2006

Digital Resources/Online E-Resources

18
Hollis-Eden Pharmaceuticals Presents Positive Preclinical Data on Compounds Targeting Hormone Refractory Prostate Cancer
Material Type:
Newspaper Article
Add to My Research

Hollis-Eden Pharmaceuticals Presents Positive Preclinical Data on Compounds Targeting Hormone Refractory Prostate Cancer

Business Wire, 2006-09-13

COPYRIGHT 2006 Business Wire, Inc.

Digital Resources/Online E-Resources

19
New Phase III Data Showed Significant Glucose-Lowering Efficacy of JANUVIA(TM), an Investigational Medicine for Type 2 Diabetes, When Taken Simultaneously with Metformin
Material Type:
Newspaper Article
Add to My Research

New Phase III Data Showed Significant Glucose-Lowering Efficacy of JANUVIA(TM), an Investigational Medicine for Type 2 Diabetes, When Taken Simultaneously with Metformin

Business Wire, 2006-09-14

COPYRIGHT 2006 Business Wire, Inc.

Digital Resources/Online E-Resources

20
invivodata Initiates Set of ePRO Clinical Trials in Japan; Exclusive Relationship With Dendrite Japan Ensures Seamless Trial Execution
Material Type:
Newspaper Article
Add to My Research

invivodata Initiates Set of ePRO Clinical Trials in Japan; Exclusive Relationship With Dendrite Japan Ensures Seamless Trial Execution

Business Wire, 2006-09-14

COPYRIGHT 2006 Business Wire, Inc.

Digital Resources/Online E-Resources

Results 1 - 20 of 1,043  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2005  (9)
  2. 2005 To 2008  (77)
  3. 2009 To 2012  (205)
  4. 2013 To 2017  (315)
  5. After 2017  (438)
  6. More options open sub menu

Searching Remote Databases, Please Wait